Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Inspira Technologies Oxy B.H.N. Ltd. (IINN) Stock Forecast & Price Prediction Israel | NASDAQ | Healthcare | Medical Devices
$1.11
+0.00 (0.00%)Did IINN Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Inspira Technologies is one of their latest high-conviction picks.
Based on our analysis of 4 Wall Street analysts, IINN has a bullish consensus with a median price target of $5.00 (ranging from $5.00 to $5.00). The overall analyst rating is N/A (N/A/10). Currently trading at $1.11, the median forecast implies a 350.5% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for IINN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 2, 2025 | Litchfield Hills | Theodore O'Neill | Buy | Initiates | $2.00 |
| Jan 25, 2023 | Aegis Capital | David Bouchey | Buy | Maintains | $13.00 |
| Dec 31, 2021 | Aegis Capital | Buy | Maintains | $N/A | |
| Nov 1, 2021 | Aegis Capital | Nathan Weinstein | Buy | Maintains | $10.00 |
| Aug 26, 2021 | Aegis Capital | Buy | Initiates | $N/A |
The following stocks are similar to Inspira Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops innovative respiratory support solutions.
The company generates revenue by offering advanced respiratory support devices, specifically a minimally invasive blood oxygenation device aimed at improving treatment for acute respiratory failure. By targeting hospitals and emergency facilities, Inspira Technologies enhances respiratory care, thereby positioning itself as a key player in the healthcare sector.
Inspira Technologies' technology is designed to allow patients to remain conscious and mobile, addressing a significant gap in traditional mechanical ventilation. The company aims to transform respiratory support and improve patient outcomes, making it an attractive investment opportunity in the growing health-tech market.
Healthcare
Medical Devices
38
Mr. Dagi Shahar Ben-Noon
Israel
2021
Inspira Technologies (NASDAQ: IINN) announced a strategic expansion of its blood laboratory capabilities, positioning the company for future growth in innovative life-support and diagnostic technologies.
Inspira Technologies' expansion into blood laboratory capabilities signals potential for enhanced revenue streams and competitive advantage, likely boosting investor confidence and stock performance.
Inspira Technologies (NASDAQ: IINN) has completed a clinical study for its non-invasive blood sensor, HYLA, and is preparing for regulatory submission and commercialization.
Completion of the clinical study for Inspira's non-invasive blood sensor signals progress toward regulatory approval and potential market entry, which could enhance revenue and market position.
Inspira Technologies (NASDAQ: IINN) has submitted its FDA-cleared INSPIRAโข ART100 system to the UAE's MOHAP, with final approval anticipated soon, facilitating Gulf region market entry.
Completion of regulatory submission for the ART100 system in the UAE signals potential market expansion, which could drive revenue growth and enhance investor confidence in Inspira Technologies.
Inspira Technologies (NASDAQ: IINN) announced the appointment of Mike Hershkovitz as VP of Global Sales and Sivan Matza as an independent board member, enhancing its leadership for global growth.
Leadership changes can signal strategic shifts and impact company direction, influencing investor confidence and stock performance. New appointments may enhance governance and operational effectiveness.
Inspira Technologies (NASDAQ: IINN) has formed a strategic collaboration with Bites Learning Ltd., focusing on AI-driven digital training and performance solutions.
Inspira's collaboration with Bites enhances its technological capabilities, potentially driving growth and innovation, which may positively impact its stock performance and market competitiveness.
Inspira achieved key milestones by June 30, 2025, including $49.5 million in purchase orders, clinical validation in hospitals, and 97.35% accuracy for its HYLA blood sensor.
Inspira's strong purchase orders, high accuracy in its blood sensor, and patent protections signal robust growth potential, enhancing investor confidence in the company's future performance.
Based on our analysis of 4 Wall Street analysts, Inspira Technologies Oxy B.H.N. Ltd. (IINN) has a median price target of $5.00. The highest price target is $5.00 and the lowest is $5.00.
According to current analyst ratings, IINN has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.11. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict IINN stock could reach $5.00 in the next 12 months. This represents a 350.5% increase from the current price of $1.11. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering advanced respiratory support devices, specifically a minimally invasive blood oxygenation device aimed at improving treatment for acute respiratory failure. By targeting hospitals and emergency facilities, Inspira Technologies enhances respiratory care, thereby positioning itself as a key player in the healthcare sector.
The highest price target for IINN is $5.00 from at , which represents a 350.5% increase from the current price of $1.11.
The lowest price target for IINN is $5.00 from at , which represents a 350.5% increase from the current price of $1.11.
The overall analyst consensus for IINN is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.00.
Stock price projections, including those for Inspira Technologies Oxy B.H.N. Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.